Secukinumab shows reassuring low immunogenicity

Br J Dermatol. 2017 Mar;176(3):573-574. doi: 10.1111/bjd.15332.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal*
  • Antibodies, Monoclonal, Humanized
  • Humans
  • Psoriasis*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • secukinumab